Hormonal Carcinogenesis

Lab publications

  • International Journal of Cancer

    01/10/2019

    International Journal of Cancer

    FGF2 Induces Breast Cancer Growth through Ligand-Independent Activation and Recruitment of ERα and PRBΔ4 Isoform to MYC Regulatory Sequences

    Giulianelli S, Riggio M, Guillardoy T, Pérez Piñero C, Gorostiaga MA, Sequeira G, Pataccini G, Abascal MF, Toledo MF, Jacobsen BM, Guerreiro AC, Barros A, Novaro V, Monteiro FL, Amado F, Gass H, Abba M, Helguero LA, Lanari C.

  • Journal of Endocrinology

    07/10/2018

    Endocrine related cancer

    Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer

    Lamb CA, Fabris VT, Jacobsen B, Molinolo AA, Lanari C.

  • 10/01/2018

    Hormones and Cancer

    Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer

    Sahores A, Figueroa V, May M, Liguori M, Rubstein A, Fuentes C, Jacobsen BM, Elía A, Rojas P, Sequeira GR, Álvarez MM, González P, Gass H, Hewitt S, Molinolo A, Lanari C, Lamb CA.

  • Journal of Cellular Physiology

    08/01/2018

    Journal of Cellular Physiology

    PDGFB as a vascular normalization agent in an ovarian cancer model treated with a gamma-secretase inhibitor

    Pazos MC, Sequeira GR, Bocchicchio S, May M, Abramovich D, Parborell F, Tesone M, Irusta G.

  • Current Drug Targets

    13/12/2017

    Current Cancer Drug Targets

    Targeting FGFR with BGJ398 in breast cancer: Effect on tumor growth and metastasis

    Sahores A, May M, Sequeira G, Fuentes C, Jacobsen B, Lanari C, Lamb CA.

  • Journal of Pathology. Clinical research

    10/10/2017

    Journal of Pathology. Clinical research

    Isoform specificity of progesterone receptor antibodies

    Fabris V, Abascal MF, Giulianelli S, May M, Sequeira GR, Jacobsen B, Lombès M, Han J, Tran L, Molinolo A, Lanari C.

  • Journal of the National Cancer Institute

    01/07/2017

    Journal of the National Cancer Institute

    Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

    Rojas PA, May M, Sequeira GR, Elia A, Alvarez M, Martínez P, Gonzalez P, Hewitt S, He X, Perou CM, Molinolo A, Gibbons L, Abba MC, Gass H, Lanari C.

  • Current Drug Targets

    30/03/2017

    Current Cancer Drug Targets

    The β2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB-231 Cell Line

    Rivero EM, Piñero CP, Gargiulo L, Entschladen F, Zänker K, Bruzzone A, Lüthy IA.

  • 13/03/2017

    Scientific Reports

    AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins

    Riggio M, Perrone MC, Polo ML, Rodriguez MJ, May M, Abba M, Lanari C, Novaro V.

  • Sub-cellular biochemistry

    01/03/2017

    Journal of Mammary Gland Biology and Neoplasia

    A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer

    Gargiulo L, May M, Rivero EM, Copsel S, Lamb C, Lydon J, Davio C, Lanari C, Lüthy IA, Bruzzone A.